Developing methodologies for evaluating community-wide health promotion

被引:16
作者
SansonFisher, R
Redman, S
Hancock, L
Halpin, S
Clarke, P
Schofield, M
Burton, R
Hensley, M
Gibberd, R
Reid, A
Walsh, R
Girgis, A
Burton, L
McClintock, A
Carter, R
Donner, A
Green, S
机构
[1] UNIV NEWCASTLE, FAC MED & HLTH SCI, WALLSEND, NSW 2287, AUSTRALIA
[2] AUSTRALIAN INST HLTH, CANBERRA, ACT, AUSTRALIA
[3] NSW CANC COUNCIL, SYDNEY, NSW, AUSTRALIA
[4] UNIV WESTERN ONTARIO, LONDON, ON N6A 3K7, CANADA
[5] NCI, BETHESDA, MD 20892 USA
基金
英国医学研究理事会;
关键词
community; evaluation; health promotion;
D O I
10.1093/heapro/11.3.227
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
There has been growing recognition that health promotion programs which target whole communities are more likely to be effective in changing health behaviour. However, studies evaluating the impact of communitywide health promotion programs rarely use adequate methodology. Randomised control trials where multiple whole communities are randomly assigned to control and intervention groups are optimum if evaluators hope to validly attribute changes in health behaviour to the intervention. However, such trials present a number of difficulties including cost and feasibility limitations and the evolving nature of statistical techniques. This paper proposes applying a fairly well-accepted phased evaluation approach to the evaluation of community participation programs, using three defined phases. Phase I consists of small-scale studies to develop the measures and assess acceptability and feasibility of the intervention; Phase 2 consists of studies in a small number of communities designed to trial the intervention in the real world; Phase 3 studies use an appropriate number of entire communities to provide valid evidence of efficacy of the intervention. It is suggested that criteria be resolved to identify adequate studies at each stage and that advantages and limitations of Phase I and 2 studies be clearly identified. The paper describes the major design, sampling and analysis considerations for a Phase 3 study.
引用
收藏
页码:227 / 236
页数:10
相关论文
共 36 条
[12]   A METHODOLOGICAL REVIEW OF NON-THERAPEUTIC INTERVENTION TRIALS EMPLOYING CLUSTER RANDOMIZATION, 1979-1989 [J].
DONNER, A ;
BROWN, KS ;
BRASHER, P .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1990, 19 (04) :795-800
[13]   RANDOMIZATION BY CLUSTER - SAMPLE-SIZE REQUIREMENTS AND ANALYSIS [J].
DONNER, A ;
BIRKETT, N ;
BUCK, C .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1981, 114 (06) :906-914
[14]   THE STANFORD 5-CITY PROJECT - DESIGN AND METHODS [J].
FARQUHAR, JW ;
FORTMANN, SP ;
MACCOBY, N ;
HASKELL, WL ;
WILLIAMS, PT ;
FLORA, JA ;
TAYLOR, CB ;
BROWN, BW ;
SOLOMON, DS ;
HULLEY, SB .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1985, 122 (02) :323-334
[15]   EFFECTS OF COMMUNITY-WIDE EDUCATION ON CARDIOVASCULAR-DISEASE RISK-FACTORS - THE STANFORD 5-CITY PROJECT [J].
FARQUHAR, JW ;
FORTMANN, SP ;
FLORA, JA ;
TAYLOR, CB ;
HASKELL, WL ;
WILLIAMS, PT ;
MACCOBY, N ;
WOOD, PD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (03) :359-365
[16]   COMMUNITY-BASED MODEL OF LIFE-STYLE INTERVENTION TRIALS [J].
FARQUHAR, JW .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1978, 108 (02) :103-111
[17]  
GIFFEN CA, 1991, J NATL CANCER I, V83, P1620, DOI 10.1093/jnci/83.22.1620
[18]  
GLYNN TJ, 1993, CANCER DETECT PREV, V17, P507
[19]  
Green L.W., 1991, HLTH PROMOTION PLANN
[20]   DETERMINING OPTIMAL THERAPY - RANDOMIZED TRIALS IN INDIVIDUAL PATIENTS [J].
GUYATT, G ;
SACKETT, D ;
TAYLOR, DW ;
CHONG, J ;
ROBERTS, R ;
PUGSLEY, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (14) :889-892